SCHEMBL7744660

SCHEMBL7744660

CCCCC(=O)Nc1oc(-c2ccccc2-c2cccc(O)c2)nc1-c1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.44
FLT1 P17948 1/20 0.44
FLT4 P35916 1/20 0.44
HPGD P15428 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
USP2 O75604 1/20 0.43
TSHR P16473 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ADORA1 P30542 3/20 0.42
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 4/20 0.41
HSD17B10 Q99714 2/20 0.41
ADORA3 P0DMS8 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
GSK3B P49841 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7739024 0.93 KDR (0.50) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744194 0.93 ADORA1 (0.46) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744165 0.90 HPGD (0.44) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744044 0.90 HPGD (0.44) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7746631 0.89 KDR (0.42) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744655 0.86 HPGD (0.50) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744076 0.86 KDR (0.46) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7739010 0.86 KDR (0.47) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7739089 0.86 KDR (0.60) KDRFLT1FLT4SMN1; SMN2KDM4E
SCHEMBL7744659 0.85 KDR (0.50) KDRFLT1FLT4HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed